High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
- PMID: 11529860
- DOI: 10.1046/j.1365-2141.2001.02946.x
High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden
Abstract
Factor V Leiden (FVL)-carrying relatives of selected patients with venous thromboembolism (VTE) have much higher venous thrombotic risks than FVL-carrying relatives of unselected consecutive patients with VTE. To find an explanation for this, we explored other risk factors of VTE, in particular the presence of high factor VIII levels, in a retrospective follow-up study. We assessed levels of factor VIII, factor IX, fibrinogen, protein C, protein S, antithrombin, the presence of prothrombin 20210A, and the occurrence of VTE in 61 first-degree relatives of 12 selected thrombophilic families harbouring FVL, and 183 first-degree relatives of 47 unselected families of FVL carriers with a first VTE. In all families, FVL appeared to be an independent risk factor for VTE. Higher thrombosis incidence rates were found in carriers of both FVL and high factor VIII levels (> or = 150 IU/dl), while high levels of factor VIII appeared to be an independent thrombotic risk factor only in selected thrombophilic families. The fraction of individuals with more than one prothrombotic coagulation disorder was 10% higher in selected families. These results and the higher thrombotic risks we found in the thrombophilic families favour the hypothesis that other unknown co-existing genetic defects contribute to thrombophilia.
Similar articles
-
Venous thrombotic risk in family members of unselected individuals with factor V Leiden.Thromb Haemost. 2000 Jun;83(6):817-21. Thromb Haemost. 2000. PMID: 10896231
-
Factor V Leiden: the venous thrombotic risk in thrombophilic families.Br J Haematol. 2000 Sep;110(4):939-45. doi: 10.1046/j.1365-2141.2000.02236.x. Br J Haematol. 2000. PMID: 11054086
-
Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.Haematologica. 2002 Oct;87(10):1068-73. Haematologica. 2002. PMID: 12368162
-
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.Haematologica. 2007 Aug;92(8):1107-14. doi: 10.3324/haematol.10234. Haematologica. 2007. PMID: 17650440 Review.
-
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853. JAMA. 2009. PMID: 19531787 Review.
Cited by
-
Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment.Heliyon. 2024 May 1;10(12):e30615. doi: 10.1016/j.heliyon.2024.e30615. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38975109 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical